Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peroxisomes and Mitochondria01:30

Peroxisomes and Mitochondria

95.6K
Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
95.6K
Common Ion Effect03:24

Common Ion Effect

46.7K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
46.7K
Mitochondria01:37

Mitochondria

20.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
20.4K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

13.4K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.4K
Therapeutic Index01:13

Therapeutic Index

6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Common Respiratory Disorders01:31

Common Respiratory Disorders

1.4K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.

Journal of molecular and cellular cardiology·2024
Same author

Inpatient Hospital Costs, Emergency Department Visits, and Readmissions for Revision Hip and Knee Arthroplasty.

The Journal of arthroplasty·2024
Same author

Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates.

Bioorganic & medicinal chemistry·2024
Same author

Naked mole-rats have distinctive cardiometabolic and genetic adaptations to their underground low-oxygen lifestyles.

Nature communications·2024
Same author

In vivo mitochondria-targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy.

The Journal of physiology·2024
Same author

A break in mitochondrial endosymbiosis as a basis for inflammatory diseases.

Nature·2024

Related Experiment Video

Updated: Feb 3, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.5K

Mitochondria as a therapeutic target for common pathologies.

Michael P Murphy1, Richard C Hartley2

  • 1Medical Research Council (MRC) Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.

Nature Reviews. Drug Discovery
|November 6, 2018
PubMed
Summary

Mitochondrial dysfunction contributes to common diseases beyond genetic disorders. Targeting mitochondria offers new therapeutic opportunities for prevalent conditions like neurodegeneration and heart failure.

More Related Videos

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
13:42

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria

Published on: September 7, 2012

22.1K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K

Related Experiment Videos

Last Updated: Feb 3, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.5K
Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
13:42

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria

Published on: September 7, 2012

22.1K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cell Biology

Background:

  • Mitochondrial dysfunction is implicated in numerous common diseases, including neurodegenerative disorders, metabolic diseases, heart failure, ischemia-reperfusion injury, and protozoal infections.
  • Therapeutic development has historically focused on rare genetic disorders affecting mitochondria, but broader applications are now recognized.
  • Mitochondria are crucial cellular organelles whose dysfunction significantly impacts overall health and disease pathology.

Purpose of the Study:

  • To review the emerging strategies for developing mitochondrial therapies for common pathologies.
  • To discuss the opportunities and challenges in the field of mitochondrial pharmacology.
  • To highlight the potential of targeting mitochondria for a wide range of prevalent diseases.

Main Methods:

  • Literature review of current research and clinical trials in mitochondrial pharmacology.
  • Analysis of therapeutic strategies aimed at restoring mitochondrial function.
  • Discussion of the challenges and future directions in developing mitochondrial drugs.

Main Results:

  • Several therapeutic strategies for restoring mitochondrial function are under development.
  • A limited number of mitochondrial agents have progressed to clinical trials.
  • Mitochondrial dysfunction is a significant factor in the pathology of many common, highly prevalent diseases.

Conclusions:

  • Mitochondria represent a promising drug target for common diseases beyond rare genetic conditions.
  • Further development of mitochondrial pharmacology is crucial for addressing prevalent health issues.
  • Overcoming current challenges is key to realizing the therapeutic potential of targeting mitochondria.